Molina R - Search Results

1

Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC.

Molina R, Torres MD, Moragas M, Filella X, Jo J, Giménez N, Traserra J, Ballesta AM. Molina R, et al. Anticancer Res. 1995 Mar-Apr;15(2):479-84. Anticancer Res. 1995. PMID: 7763026

2

CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA.

Molina R, Filella X, Augé JM, Bosch E, Torne A, Pahisa J, Lejarcegui JA, Rovirosa A, Mellado B, Ordi J, Biete A. Molina R, et al. Anticancer Res. 2005 May-Jun;25(3A):1765-71. Anticancer Res. 2005. PMID: 16033097 Free article.

3

Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.

Molina R, Auge JM, Filella X, Viñolas N, Alicarte J, Domingo JM, Ballesta AM. Molina R, et al. Anticancer Res. 2005 May-Jun;25(3A):1773-8. Anticancer Res. 2005. PMID: 16033098 Free article.

4

A prospective study of tumor markers CA 125 and CA 19.9 in patients with epithelial ovarian carcinomas.

Molina R, Ojeda B, Filella X, Borras G, Jo J, Mas E, Lopez JJ, Ballesta A. Molina R, et al. Tumour Biol. 1992;13(5-6):278-86. doi: 10.1159/000217776. Tumour Biol. 1992. PMID: 1290025

5

Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant disease.

Filella X, Molina R, Jo J, Bedini JL, Joseph J, Ballesta AM. Filella X, et al. Among authors: molina r. Bull Cancer. 1992;79(3):271-7. Bull Cancer. 1992. PMID: 1392166 Review.

6

SCC antigen measured in malignant and nonmalignant diseases.

Molina R, Filella X, Torres MD, Ballesta AM, Mengual P, Cases A, Balaque A. Molina R, et al. Clin Chem. 1990 Feb;36(2):251-4. Clin Chem. 1990. PMID: 2302769

7

CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels.

Molina R, Agusti C, Mañe JM, Filella X, Jo J, Joseph J, Giménez N, Estapé J, Ballesta AM. Molina R, et al. Int J Biol Markers. 1994 Apr-Jun;9(2):96-101. doi: 10.1177/172460089400900206. Int J Biol Markers. 1994. PMID: 7523548 Clinical Trial.

8

Carcinoembryonic antigen in staging and follow-up of patients with solid tumors.

Ballesta AM, Molina R, Filella X, Jo J, Giménez N. Ballesta AM, et al. Among authors: molina r. Tumour Biol. 1995;16(1):32-41. doi: 10.1159/000217926. Tumour Biol. 1995. PMID: 7863220 Review.

9

Study of a new tumor marker, CYFRA 21-1, in malignant and nonmalignant diseases.

Molina R, Agusti C, Filella X, Jo J, Joseph J, Giménez N, Ballesta AM. Molina R, et al. Tumour Biol. 1994;15(6):318-25. doi: 10.1159/000217908. Tumour Biol. 1994. PMID: 7997803

10

CEA as a prognostic factor in colorectal cancer.

Filella X, Molina R, Piqué JM, Grau JJ, Garcia-Valdecasas JC, Biete A, Novell F, Astudillo E, Bordas JM, Campo E, et al. Filella X, et al. Among authors: molina r. Anticancer Res. 1994 Mar-Apr;14(2B):705-8. Anticancer Res. 1994. PMID: 8010730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,163 results

Search Page

Filters